• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21983 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 1 - overview of heart and lung transplantation in Québec]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - vascular, cardiovascular and thoracic surgery]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Pembrolizumab for melanoma treatment in adults]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Heart disease in children: can children be helped to cope with their illness through psychological support?]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of non-pharmacological interventions aimed at commerce in controlling the spread of COVID-19]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - otolaryngology and oral, maxillofacial and head and neck surgery]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Pembrolizumab in non-small-cell lung cancer]
2022     Institute for Clinical and Economic Review (ICER) Unsupported price increase report: unsupported price increases occurring in 2021
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Social isolation in the elderly: what measures can prevent or counteract social isolation?]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of non-pharmacological interventions aimed at workplaces in controlling the spread of COVID-19]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - eye surgery]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Pembrolizumab for patients with clear-cell renal-cell carcinoma]
2022     Institute for Clinical and Economic Review (ICER) California unsupported price increase report; an evaluation of drug price increases during 2020 in California
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Blood values: do older people benefit from regular determination of vitamin B12 and vitamin D levels in the blood?]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Upper airway stimulation for moderate-to-severe sleep apnoea. Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: revision of criteria for the withholding and termination of resuscitation by paramedics in prehospital setting]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Pembrolizumab for advanced or metastatic urothelial carcinoma]
2022     Institute for Clinical and Economic Review (ICER) The next generation of rare disease drug policy: ensuring both innovation and affordability
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mobility disorders: does the Feldenkrais method help?]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Subcutaneous implantable cardioverter-defibrillator (S-ICD). Update 2022
2022     Austrian Institute for Health Technology Assessment (AIHTA) CAR-T cell therapy: Contrasting the evidence from pivotal trials with the real world evidence (RWE)
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transvascular implantation of a coronary sinus reducing stent. Update 2022
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 3 - overview of renal and pancreatic transplantation in Québec]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Developmental vision disorders: do children and adolescents benefit from active vision training?]
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for the treatment of primary membranous nephropathy
2022     Austrian Institute for Health Technology Assessment (AIHTA) Hepatic and portal vein embolisation prior to major hepatectomy
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: chronic obstructive pulmonary disease- detection, diagnosis, optimal use of medications and inhalation devices, and global management]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Microwave ablation for liver tumours
2022     Austrian Institute for Health Technology Assessment (AIHTA) Osteopathy: effectiveness and safety for musculoskeletal pain and overview of training and quality requirements
2022     NIHR Health Technology Assessment programme Exercise to prevent shoulder conditions in patients undergoing breast cancer treatment. The PRevention Of Shoulder Problems Study (PROSPER)
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pharmacotherapy for transplant ineligible multiple myeloma
2022     Austrian Institute for Health Technology Assessment (AIHTA) His-bundle-pacing for patients requiring a permanent pacemaker or cardiac resynchronisation
2022     Austrian Institute for Health Technology Assessment (AIHTA) Chemosaturation with percutaneous hepatic perfusion for patients with liver cancer
2022     NIHR Health Technology Assessment programme SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
2022     Austrian Institute for Health Technology Assessment (AIHTA) Lower esophageal sphincter devices for laparoscopic surgery in patients with gastroesophageal reflux disease (GERD)
2022     Health Technology Wales (HTW) Convalescent plasma therapy for the treatment of COVID-19
2022     Belgian Health Care Knowledge Centre (KCE) Evaluation of Shingrix vaccine against herpes zoster
2022     Health Technology Wales (HTW) Extreme hypofractionated radiotherapy (EHFRT) for localised prostate cancer
2022     Austrian Institute for Health Technology Assessment (AIHTA) Child and adolescent mental health care models: a scoping review
2022     Austrian Institute for Health Technology Assessment (AIHTA) [Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening programme]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: RASopathies Next-generation Sequencing Panel]
2022     Health Information and Quality Authority (HIQA) COVID-19 Evidence Synthesis: International review of guidance on the use of face masks to mitigate the spread of SARS-CoV-2 infection
2022     NIHR Health Technology Assessment programme Antibiotics for lower respiratory tract infection in children presenting in primary care (ARTIC PC)
2022     Health Technology Wales (HTW) Video laryngoscopes for use in pre-hospital care
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cardiac monitoring with textile wearable Holter for atrial fibrillation detection after cryptogenic stroke]
2022     WorkSafeBC N-acetylcysteine (NAC) as treatment for complex regional pain syndrome (CRPS): 2022 Update
2022     NIHR Health Technology Assessment programme Evaluation of the Healthy Start Voucher Scheme in UK: a natural experiment using the Growing Up in Scotland record linkage study and the Infant Feeding Survey
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Peer support programs for youth mental health
2022     WorkSafeBC Antalgic gait, limp, osteoarthritis - what happens to the weight-bearing joints?
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Use of indocyanine green in colorectal and hepato-biliopancreatic surgery]
2022     WorkSafeBC SANUWAVE therapy for wound healing
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Evaluation of several vaccination strategies against rotavirus in Spain. Safety, efficacy, effectiveness and efficiency]
2022     NIHR Health Technology Assessment programme DexEnceph- Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial and NonHSV Cohort Study
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of adult patients with immune thrombocytopenia after failure of first-line therapies
2022     WorkSafeBC Balloon spacer as treatment for massive rotator cuff tear
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Internet-delivered cognitive behavioural therapy in the treatment of chronic non-cancer pain
2022     WorkSafeBC Satir brief transformational therapy as treatment for trauma-related disorders including PTSD
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for argininosuccinic aciduria (ASA)]
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Systematic review on diagnosis and care of reactive attachment disorder]
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraocular lens implantation for infants with aphakia: a systematic review of clinical effectiveness and cost-effectiveness
2022     Norwegian Institute of Public Health (NIPH) [Intravenous ketamine for treatment-resistant depression and suicidal ideation: a single technology assessment - mapping]
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Safety and effectiveness of percutaneous tricuspid valve repair]
2022     NIHR Health Technology Assessment programme The Best Services Trial (BeST?): Effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness of social distancing measures, in the context of the COVID-19]
2022     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Occupational exposures and asthma and COPD]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Treprostinil in chronic thromboembolic pulmonary hypertension (group 4)]
2022     The Regional Health Technology Assessment Centre (HTA-centrum) Osseointegrated upper limb prostheses with and without neuromuscular control: benefits and risks
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Irreversible electroporation in pancreatic cancer]
2022     The Regional Health Technology Assessment Centre (HTA-centrum) [Benefits and risks of caseload midwifery: continuity of midwifery team during antenatal, intrapartal, and postnatal care]
2022     NIHR Health Technology Assessment programme Accuracy of a rapid intrapartum test for maternal group B streptococcal colonisation and its potential to reduce antibiotic usage in mothers with risk factors (GBS2)
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: integration of real-world data and evidence into assessments to support decision-making in the pharmaceutical sector]
2022     Austrian Institute for Health Technology Assessment (AIHTA) Quality registries in dementia care: mapping of registries to improve quality and service delivery
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital breast tomosynthesis]
2022     The Regional Health Technology Assessment Centre (HTA-centrum) Active or semi-active robotic arm-assisted versus manual knee arthroplasty: benefits and risks
2022     Penn Medicine Center for Evidence-based Practice (CEP) Medications for treating moderate to severe alcohol withdrawal syndrome in critical care and emergency department patients
2022     Malaysian Health Technology Assessment (MaHTAS) Molecular profiling assays in early breast cancer
2022     The Regional Health Technology Assessment Centre (HTA-centrum) Effectiveness and safety of surgical procedures to treat apical prolapse - comparison of sacrospinous fixation, laparoscopic sacrocolpopexy/sacrohysteropexy, and the Manchester procedure
2022     NIHR Health Technology Assessment programme Paclitaxel assisted balloon Angioplasty of Venous stenosis in haEmodialysis access: The PAVE Trial. A multicentre double-blind randomised controlled trial in haemodialysis patients with a stenosis in a native arteriovenous fistula
2022     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines and clinical pathways for management of upper GI bleeding
2022     Malaysian Health Technology Assessment (MaHTAS) Immunotherapy for PD-L1 positive advanced non-small cell lung cancer
2022     NIHR Health Technology Assessment programme Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial
2022     Penn Medicine Center for Evidence-based Practice (CEP) Peripartum or postnatal care disparities and equity
2022     Malaysian Health Technology Assessment (MaHTAS) Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for non-small cell lung cancer
2022     NIHR Health Technology Assessment programme EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation
2022     Malaysian Health Technology Assessment (MaHTAS) Robotic arm-assisted surgery in total hip arthroplasty, total knee arthroplasty and unicompartmental knee arthroplasty
2022     NIHR Health Technology Assessment programme Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation (LiverTOL-Dx Trial)
2022     WorkSafeBC Clinical accuracy of rapid antigen tests for COVID-19
2022     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Ambulatory blood pressure monitoring (ABPM) in the identification of circadian patterns in patients with arterial hypertension: evaluation of safety, effectiveness, and efficiency]
2022     NIHR Health Technology Assessment programme Unspecified living kidney donation in the UK: barriers to implementation and delivery
2022     Penn Medicine Center for Evidence-based Practice (CEP) Workplace violence in healthcare settings
2022     WorkSafeBC Functional neurology as treatment for post-traumatic brain injury
2022     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety, efficacy/effectiveness, and efficiency of teleconsultation in primary care, and the organizational, ethical, social, and legal aspects linked to its use]
2022     NIHR Health Technology Assessment programme Delivering primary health care to homeless people: an evaluation of the integration, effectiveness and costs of different models
2022     Health Technology Wales (HTW) Electronic blood management systems for blood transfusions
2022     WorkSafeBC Dupuytren's contracture and wrist fractures
2022     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Evaluation of the safety, efficacy/effectiveness, and efficiency of stereotactic body radiation therapy (SBRT) in lung, prostate, and liver cancer]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of Synvisc and Synvisc One for the management of knee osteoarthritis]
2022     WorkSafeBC Percussion therapy for neuropathic pain